FDA Mulls Over Approval Of Controversial Alzheimer's Drug

The FDA is poised to decide whether to approve aducanumab, a drug to treat Alzheimer's. It's proved highly effective at removing the sticky amyloid plaques associated with the disease from the brain.

[Copyright 2021 NPR]